Drug Management of Juvenile Idiopathic Arthritis in Covid-19 Context : Impact on Therapeutical Managment

Last updated: May 28, 2020
Sponsor: University Hospital, Brest
Overall Status: Active - Recruiting

Phase

N/A

Condition

Rheumatoid Arthritis (Pediatric)

Arthritis And Arthritic Pain

Joint Injuries

Treatment

N/A

Clinical Study ID

NCT04407923
RHUMAJICOVID (29BRC20.0148)
  • Ages < 17
  • All Genders

Study Summary

The current situation of Sars-Cov-2 pandemic generates fears in the general population. Among patients receiving long-term immunomodulatory drugs, especially in the context of auto-immune diseases, there may be legitimates interrogations about the appropriateness of continuing treatment, without modification, in the current context. Juvenile Idiopathic Arthritis is concerns by these fears (the patient and their parents). Patients are treated by several classes of immunomodulatory drugs, including non-steroidal anti-inflammatory drugs, corticosteroids and disease modifying anti-rheumatic drugs. The present study will characterize this issue by defining the proportion of patients whose usual treatment of Juvenile Idiopathic Arthritis has been modified in relation to the actual sanitary crisis, and also to return to school.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Juvenile Idiopathic Arthritis satisfying Edmonton criteria

  • Ongoing DMARD therapy or AINS for 3 months

Exclusion

Exclusion Criteria:

  • Inhability to consent

Study Design

Total Participants: 150
Study Start date:
May 25, 2020
Estimated Completion Date:
November 25, 2020

Connect with a study center

  • CH de Belfort

    Belfort, 90015
    France

    Site Not Available

  • CHU de Bordeaux

    Bordeaux, 33000
    France

    Site Not Available

  • CHRU de Brest

    Brest, 29609
    France

    Active - Recruiting

  • AP-HP Hôpital Kremlin-Bicêtre

    Le Kremlin-Bicêtre, 94275
    France

    Site Not Available

  • CHU de Poitiers

    Poitiers, 86021
    France

    Site Not Available

  • CHU de Rennes

    Rennes, 35000
    France

    Site Not Available

  • CHU de Strasbourg

    Strasbourg, 67200
    France

    Site Not Available

  • CHU de Nancy

    Vandœuvre les Nancy, 54711
    France

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.